Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
drugs
3
×
fda
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
boston
clinical trials
san diego blog main
san diego top stories
akcea therapeutics
allopregnanolone
alnylam pharmaceuticals
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
cancer
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
entrectinib
european medicines agency
express scripts
foundation medicine
harvard pilgrim health care
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
institute for clinical and economic review
josh bilenker
keytruda
larotrectinib
loxo oncology
marc goodman
What
drug
3
×
fda
medicine
3
×
approved
new
oks
alnylam
approves
brexanolone
cancer
cells
deeper
depression
devastating
disorder
dna
ema
employ
europe
fast
fingerprint
follows
gene
genetic
going
harmful
hits
interference
make
matter
method
moms
mute
nd
partum
post
potentially
protein
relief
rna
Language
Current search:
medicine
×
drug
×
" national top stories "
×
drugs
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug